Cryptogenic stroke is a significant clinical problem
OverviewStroke is the third leading cause of death worldwide with 20M annual events. In the US, each year there are 800K strokes, of which 195K are recurrent (Figure). Additionally, there are over 500K Transient Ischemic Attacks (TIAS), or “mini strokes”, which often precede strokes. Despite advances in imaging , cardiac monitoring, patient history assessment, and clinical examination, the cause remains unknown (or “cryptogenic”) in up to 40% of ischemic strokes, representing 240,000 to 280,000 US cases each year. Of these 280,000 cryptogenic strokes, an estimated 72,000 will die within 1 year. Furthermore, a significant number of TIAs are oftened misdiagnosed or difficult to distinguish from mimics (migraines, seizures). Experiencing a TIA increases the risk of stroke by 20% within 90 days. Cause drives clinical outcomes and there are no blood tests for cause of stroke or TIA. Over $40B is spent each year in the US on the diagnosis and treatment of stroke. Globally, imaging and other advanced techniques are not standard of care.
Important take aways…